文献速递肾癌与肾肿瘤

评估共享决策干预对肾细胞癌患者的影响:SDM-RCC研究方案

Evaluating the Impact of a Shared Decision-making Intervention for Patients with Renal Cell Carcinoma: The SDM-RCC Study Protocol.
PubMed 文献 · Eur Urol Oncol · 2024-09-20

SDM-RCC研究旨在评估综合共享决策(SDM)干预对肾细胞癌(RCC)患者决策过程及结局的影响,干预包括在线患者决策辅助工具(PtDAs)和医护人员(HCPs)培训。研究为在六家荷兰医院开展的多中心、前瞻性前测-后测队列,聚焦局限或转移性RCC患者,主要结局为采用OPTION-5评分观察的决策过程质量。研究结果可能从患者、HCP和观察者角度增进对RCC患者决策过程的理解。

要点

  • SDM-RCC研究评估综合共享决策干预对肾细胞癌患者决策过程和结局的影响。
  • 干预包括在线患者决策辅助工具及医护人员使用决策辅助工具和共享决策的培训。
  • 主要结局为采用OPTION-5评分观察的决策过程质量。

核心结论

  • 研究结果可能从患者、医护人员和观察者角度增进对肾细胞癌患者决策过程的理解。
  • 所实施的共享决策工具预期可支持决策过程。

研究设计与样本

  • 多中心、前瞻性前测-后测队列研究,在六家荷兰医院开展。
  • 聚焦局限或转移性肾细胞癌患者。
  • 干预包括在线患者决策辅助工具和医护人员使用决策辅助工具及共享决策的培训。

主要发现

  • 主要结局为采用OPTION-5评分观察的决策过程质量。
  • 次要结局包括感知的决策过程质量、决策质量及干预实施情况(使用统计和访谈)。
  • 定量分析将针对问卷数据进行,定性分析将针对访谈数据并基于既定框架编码进行。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of the SDM-RCC study is to evaluate the impact of a comprehensive shared decision-making (SDM) intervention for patients with renal cell carcinoma (RCC) on the decision-making process and outcomes. The intervention includes online patient decision aids (PtDAs) and training of health care professionals (HCPs) in the use of PtDAs and SDM. The study is a multicenter, prospective pretest-posttest cohort in six Dutch hospitals, focusing on patients with localized or metastatic RCC. The primary outcome is the observed quality of the decision-making process, measured using OPTION-5 scores. Secondary outcomes include perceived quality of the decision-making process, decision quality, and implementation of the intervention (user statistics and interviews). Quantitative analysis will be performed on questionnaire data, while qualitative analysis will be performed on interviews using coding based on established frameworks. The study results could improve understanding of the decision-making process for RCC patients from patient, HCP, and observer perspectives. The SDM tool implemented is expected to support the decision-making process. PATIENT SUMMARY: We are conducting a trial on the effects of a tool to support shared decision-making by patients with kidney cancer who are facing treatment decisions. This paper outlines the protocol that will be used for the trial.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Bresser CC, Garvelink MM, van den Berg BMM, et al. Evaluating the Impact of a Shared Decision-making Intervention for Patients with Renal Cell Carcinoma: The SDM-RCC Study Protocol. Eur Urol Oncol. 2024. PMID: 39304394. doi:10.1016/j.euo.2024.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。